Please use this identifier to cite or link to this item: https://hdl.handle.net/11147/14763
Full metadata record
DC FieldValueLanguage
dc.contributor.authorUzuner,E.-
dc.contributor.authorKiraz,Y.-
dc.contributor.authorBaran,Y.-
dc.date.accessioned2024-09-24T15:54:15Z-
dc.date.available2024-09-24T15:54:15Z-
dc.date.issued2020-
dc.identifier.isbn978-012819541-3-
dc.identifier.urihttps://doi.org/10.1016/B978-0-12-819541-3.00023-2-
dc.identifier.urihttps://hdl.handle.net/11147/14763-
dc.description.abstractCancer cells divide continuously without any control, rendering immortal cells. These changes cause the dynamic instability in their genomes. Therefore each cancer cell in a tumor mass has various changes for specific tumor types. Their differences should be diagnosed on the basis of mutated genes and/or proteins. After the detection of alterations in cancer cells based on the techniques and instruments of biomedicine, personalized therapy continues with preexisting drug implementations. Personalized therapy broadens the borders with circulating tumor cells causing the metastasis in distant regions, developing specific gene therapies, novel targeted drugs, and immunotherapeutics for eliminating cancerous cells precisely. Within this context, biomedicine helps humankind to merge the biological and physiological knowledge to clinical practice. In this chapter, we aimed to clarify attitudes in biomedicine from molecular changes from single tumor cells to in vivo studies to find the best therapy for a cancer patient. © 2020 Elsevier Inc. All rights reserved.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofBiodiversity and Biomedicine: Our Futureen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectcancer-cell specific sequencingen_US
dc.subjectcirculating tumor cellsen_US
dc.subjectdrug implementationsen_US
dc.subjectgene therapiesen_US
dc.subjectgenetic profilingen_US
dc.subjectgenetic testsen_US
dc.subjectimmunotherapiesen_US
dc.subjectmarker-based drug therapiesen_US
dc.subjectpersonalized therapiesen_US
dc.subjectTumor-specific changesen_US
dc.titleTumor-specific genetic profiling and therapy in biomedicineen_US
dc.typeBook Parten_US
dc.departmentIzmir Institute of Technologyen_US
dc.identifier.startpage459en_US
dc.identifier.endpage485en_US
dc.identifier.scopus2-s2.0-85147599383-
dc.relation.publicationcategoryKitap Bölümü - Uluslararasıen_US
dc.identifier.doi10.1016/B978-0-12-819541-3.00023-2-
dc.authorscopusid57242876200-
dc.authorscopusid56422406900-
dc.authorscopusid9636164400-
dc.identifier.wosqualityN/A-
dc.identifier.scopusqualityN/A-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeBook Part-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.grantfulltextnone-
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Show simple item record



CORE Recommender

Page view(s)

8
checked on Oct 14, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.